{
    "clinical_study": {
        "@rank": "10147", 
        "brief_summary": {
            "textblock": "OBJECTIVES:\n\n      I.  Determine the effect of human parathyroid hormone (1-34) on bone mass in middle-aged men\n      with idiopathic osteoporosis."
        }, 
        "brief_title": "Randomized Study of Human Parathyroid Hormone in Middle-Aged Men With Idiopathic Osteoporosis", 
        "condition": "Osteoporosis", 
        "condition_browse": {
            "mesh_term": "Osteoporosis"
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: This is a randomized, double blind, placebo controlled study. All patients\n      self-administer daily subcutaneous injections of human parathyroid hormone (1-34) or placebo\n      for a period of 2.5 years.\n\n      Patients are followed regularly for unacceptable toxicities."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        --Disease Characteristics--\n\n        Osteoporosis as defined by: Bone mineral density at the lumbar spine or femoral neck that\n        is 2.5 standard deviations below peak bone mass reference value (T score less than -2.5)\n\n        No family history of male osteoporosis\n\n        No other metabolic bone disease\n\n        --Prior/Concurrent Therapy--\n\n        Endocrine therapy:\n\n          -  No concurrent glucocorticoid therapy\n\n          -  No prior steroid use\n\n        Surgery: No prior gastrointestinal tract surgery\n\n        Other: No prior or concurrent anticonvulsant therapy\n\n        --Patient Characteristics--\n\n        Hematopoietic: Normal CBC\n\n        Hepatic: Normal liver function\n\n        Renal: Normal renal function\n\n        Other:\n\n          -  Normal thyroid function\n\n          -  Normal adrenal function\n\n          -  Normal gonadal status\n\n          -  No myeloma or other malignancy\n\n          -  No alcoholism, hypercortisolism or diabetes mellitus\n\n          -  No gastrointestinal tract disease or disorder associated with malabsorption"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "67 Years", 
            "minimum_age": "29 Years"
        }, 
        "enrollment": "36", 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004406", 
            "org_study_id": "199/13293", 
            "secondary_id": "CPS-CU-FDR001024"
        }, 
        "intervention": {
            "intervention_name": "human parathyroid hormone", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Hormones"
        }, 
        "keyword": [
            "disease-related problem/condition", 
            "osteoporosis", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "contact": {
                "last_name": "John Paul Bilezikian", 
                "phone": "212-305-6238"
            }, 
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10032"
                }, 
                "name": "Columbia University College of Physicians and Surgeons"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "overall_official": {
            "affiliation": "Columbia University", 
            "last_name": "John Paul Bilezikian", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004406"
        }, 
        "source": "FDA Office of Orphan Products Development", 
        "sponsors": {
            "collaborator": {
                "agency": "Columbia University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "FDA Office of Orphan Products Development", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "October 1999", 
        "study_design": "Allocation: Randomized, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2000"
    }, 
    "geocoordinates": {
        "Columbia University College of Physicians and Surgeons": "40.714 -74.006"
    }
}